Insider trade

Clorox (CLX): Director received 288.14 units

Christopher J Williams, Director at Clorox, reported a grant / award of 288.14 units.

288.14
Derivative units
Traded
Jun 30, 2026
Filed
Jul 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 5, 2026InsiderDirector purchased ~$429K of CLX shares in the open market
  2. May 15, 2026CongressDisclosed sale of CLX — reported range $1,001 - $15,000
  3. May 26, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 26, 2026, Linda Rendle, Chair of the Board of Directors (the “Board”) and Chief Executive Officer (“CEO”) of The Clorox Company (the “Company”), asked the Board to initiate a CEO search process, as she has made the decision to step down for health reasons.”
  4. Jun 14, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 14, 2026, the Management Development and Compensation Committee (the “MDCC”) of the Board of Directors of The Clorox Company (the “Company”) appointed Chris Hyder, age 51, to be Executive Vice President and Chief Operating Officer (“COO”) effective June 17, 2026.”

What came next

  1. Aug 3, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 6.3%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Clorox

For Clorox, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLX page.

How this filing works

Explore the data

Common questions

Which Clorox (CLX) insider traded, and how much?

Christopher J Williams, Director at Clorox, reported a grant / award of 288.14 units. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Jun 30, 2026. Filed: Jul 2, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Clorox recently?

For Clorox, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the CLX page.

Does this mean CLX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Clorox

Everything OQRO holds on this company is on its CLX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data